Terns Pharmaceuticals Inc (TERN)
6.55
-0.23
(-3.39%)
USD |
NASDAQ |
Nov 14, 16:00
6.64
+0.09
(+1.37%)
Pre-Market: 08:21
Terns Pharmaceuticals Total Return Level: 6.55 for Nov. 14, 2024
Total Return Level Chart
Historical Total Return Level Data
Date | Value |
---|---|
November 14, 2024 | 6.55 |
November 13, 2024 | 6.78 |
November 12, 2024 | 7.17 |
November 11, 2024 | 7.46 |
November 08, 2024 | 7.30 |
November 07, 2024 | 7.06 |
November 06, 2024 | 7.24 |
November 05, 2024 | 7.17 |
November 04, 2024 | 7.10 |
November 01, 2024 | 6.94 |
October 31, 2024 | 6.86 |
October 30, 2024 | 6.89 |
October 29, 2024 | 6.88 |
October 28, 2024 | 6.51 |
October 25, 2024 | 6.67 |
October 24, 2024 | 6.75 |
October 23, 2024 | 6.99 |
October 22, 2024 | 7.50 |
October 21, 2024 | 7.24 |
October 18, 2024 | 7.41 |
October 17, 2024 | 7.50 |
October 16, 2024 | 7.65 |
October 15, 2024 | 7.60 |
October 14, 2024 | 7.62 |
October 11, 2024 | 7.67 |
Date | Value |
---|---|
October 10, 2024 | 7.405 |
October 09, 2024 | 7.88 |
October 08, 2024 | 7.81 |
October 07, 2024 | 7.85 |
October 04, 2024 | 8.27 |
October 03, 2024 | 8.20 |
October 02, 2024 | 8.20 |
October 01, 2024 | 8.10 |
September 30, 2024 | 8.34 |
September 27, 2024 | 8.55 |
September 26, 2024 | 8.85 |
September 25, 2024 | 9.25 |
September 24, 2024 | 9.61 |
September 23, 2024 | 9.73 |
September 20, 2024 | 10.02 |
September 19, 2024 | 10.04 |
September 18, 2024 | 10.21 |
September 17, 2024 | 9.63 |
September 16, 2024 | 9.41 |
September 13, 2024 | 8.955 |
September 12, 2024 | 9.51 |
September 11, 2024 | 10.68 |
September 10, 2024 | 11.23 |
September 09, 2024 | 9.12 |
September 06, 2024 | 7.81 |
Total Return Level Definition
The total return level allows investors to view the performance of a security inclusive of both price appreciation and dividends/distributions. Total return level is seen as the most accurate calculation that produces returns consistent with most other sources.
Total Return Level Range, Past 5 Years
1.50
Minimum
May 11 2022
27.25
Maximum
Mar 19 2021
8.144
Average
7.08
Median
Mar 13 2024
Total Return Level Benchmarks
Eli Lilly and Co | 2270.02 |
Viking Therapeutics Inc | 53.57 |
Biomarin Pharmaceutical Inc | 65.60 |
Elite Pharmaceuticals Inc | 0.5177 |
Verrica Pharmaceuticals Inc | 0.8633 |